莫诺祖库里计划对社区老年人的执行功能的影响:一项随机对照试验
Ai Iizuka1, Susumu Ogawa1, Daisuke Cho1,2
1Research Team for Social Participation and Healthy Aging, Tokyo Metropolitan Institute For Geriatrics and Gerontology, Tokyo, Japan.
Brain and behavior
|September 27, 2025
概括
涉及创意活动的MONOZUKURI计划对老年人的执行功能产生了积极影响. 这种认知干预可能有助于防止日常生活功能下降.
科学领域:
- 老年学是指老年学的学科.
- 认知神经科学 认知神经科学
- 公共卫生 公共卫生
背景情况:
- 居住在社区的老年人容易发生认知衰退.
- 创意活动越来越多地被探索为非药物干预.
- 在MONOZUKURI计划提供了动手的创意参与.
研究的目的:
- 评估MONOZUKURI计划对老年人的认知功能的影响.
- 评估对执行功能,语言能力,注意力,处理速度,记忆和工作记忆的影响.
- 为了确定创意活动是否可以减轻认知能力下降.
主要方法:
- 一个单盲随机对照试验,有51名参与者.
- 参与手工艺和创意的干预小组 (MONOZUKURI计划).
- 积极对照组参加了健康教育讲座;认知功能在干预前和后进行了评估.
主要成果:
- 在干预组中观察到执行功能的显著改善 (Trail Making Test B部分).
- 在其他认知领域 (语言能力,注意力,处理速度,记忆,工作记忆) 没有发现显著差异.
- 蒙奥祖库里计划证明了对执行职能的特定益处.
结论:
- 蒙奥祖库里计划显示了提高老年人执行功能的潜力.
- 获得创造性技能可能有助于防止执行功能下降.
- 进一步的研究可以探索长期影响和更广泛的认知益处.
更多相关视频
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.7K
09:01A Method for Investigating Age-related Differences in the Functional Connectivity of Cognitive Control Networks Associated with Dimensional Change Card Sort Performance
Published on: May 7, 2014
10.5K
相关概念视频
Cognitive Development During Adulthood
780
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
780
Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
Alzheimer's Disease: Treatment
824
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
824
